Skip to main content
Top
Published in: Endocrine Pathology 1/2008

01-04-2008

Adrenergic Differentiation and Ret Expression in Rat Pheochromocytomas

Authors: James F. Powers, Kristen L. Picard, Abraham Nyska, Arthur S. Tischler

Published in: Endocrine Pathology | Issue 1/2008

Login to get access

Abstract

Pheochromocytomas are catecholamine-producing tumors of the adult adrenal medulla. They are rare in humans and most other species but common in laboratory rats. However, the relevance of rat pheochromocytomas as a model for their human counterparts is uncertain. Previous studies of spontaneous and drug-induced rat pheochromocytomas and the PC12 pheochromocytoma cell line suggested a distinctive noradrenergic phenotype, possibly reflecting origin from a progenitor not present in the adult human adrenal. In this study, we studied 31 pheochromocytomas derived from test and control male and female rats in toxicologic studies for expression of the epinephrine-synthesizing enzyme phenylethanolamine-N-methyltransferase (PNMT) and the receptor tyrosine kinase Ret. PNMT, which defines adrenergic chromaffin cells, is frequently expressed in human pheochromocytomas, often in tumors that also overexpress RET. We also tested for the expression of the cell cycle checkpoint protein p27Kip1, which recently was reported absent in pheochromocytomas from a strain of rats with a hereditary mixed multiple endocrine neoplasia (MEN)-like syndrome. Using immunoblots, we demonstrated PNMT expression in almost 50% of the 31 tumors, although often at lower levels than in normal rat adrenal medulla. The majority of tumors overexpressed Ret. There was no apparent correlation between PNMT and Ret. However, in this study, PNMT expression was strongly associated with tumors arising in female rats, while overexpression of Ret did not show a sex predilection. Robust expression of p27Kip1 was seen in all tumors from the toxicologic studies and also in a small sample of pheochromocytomas from Long–Evans rats, which were reported to have a mixed MEN-like syndrome in the 1980s. The present results show that rat pheochromocytomas have greater phenotypic diversity than previously believed and greater similarity to their human counterparts with respect to these two important markers. Loss of p27Kip1 does not appear to account for the high frequency of pheochromocytomas in commonly utilized rat strains.
Literature
1.
2.
go back to reference Brouwers FM, Glasker S, Nave AF, et al. Proteomic profiling of von Hippel–Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin B. Endocr Relat Cancer 14:463–71, 2007.PubMedCrossRef Brouwers FM, Glasker S, Nave AF, et al. Proteomic profiling of von Hippel–Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin B. Endocr Relat Cancer 14:463–71, 2007.PubMedCrossRef
3.
go back to reference Eisenhofer G, Huynh TT, Pacak K, et al. Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel–Lindau syndrome. Endocr Relat Cancer 11:897–911, 2004.PubMedCrossRef Eisenhofer G, Huynh TT, Pacak K, et al. Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel–Lindau syndrome. Endocr Relat Cancer 11:897–911, 2004.PubMedCrossRef
4.
go back to reference Tischler AS. Molecular and cellular biology of pheochromocytomas and extra-adrenal paragangliomas. Endocr Pathol 17:321–8, 2006.PubMedCrossRef Tischler AS. Molecular and cellular biology of pheochromocytomas and extra-adrenal paragangliomas. Endocr Pathol 17:321–8, 2006.PubMedCrossRef
5.
go back to reference Wada M, Asai N, Tsuzuki T, et al. Detection of ret homodimers in MEN 2A-associated pheochromocytomas. Biochem Biophys Res Commun 218:606–9, 1996.PubMedCrossRef Wada M, Asai N, Tsuzuki T, et al. Detection of ret homodimers in MEN 2A-associated pheochromocytomas. Biochem Biophys Res Commun 218:606–9, 1996.PubMedCrossRef
6.
go back to reference Takaya K, Yoshimasa T, Arai H, et al. The RET proto-oncogene in sporadic pheochromocytomas. Intern Med. 35:449–52, 1996.PubMedCrossRef Takaya K, Yoshimasa T, Arai H, et al. The RET proto-oncogene in sporadic pheochromocytomas. Intern Med. 35:449–52, 1996.PubMedCrossRef
7.
go back to reference Tischler AS, Powers JF, Alroy J. Animal models of pheochromocytoma. Histol Histopathol 19:883–95, 2004.PubMed Tischler AS, Powers JF, Alroy J. Animal models of pheochromocytoma. Histol Histopathol 19:883–95, 2004.PubMed
8.
go back to reference Eranko O. Nodular hyperplasia and increase of noradrenaline content in the adrenal medulla of nicotine-treated rats. Acta Pathol Microbiol Scand 36:210–8, 1955.PubMedCrossRef Eranko O. Nodular hyperplasia and increase of noradrenaline content in the adrenal medulla of nicotine-treated rats. Acta Pathol Microbiol Scand 36:210–8, 1955.PubMedCrossRef
9.
go back to reference Tischler AS, Coupland RE. Changes in structure and function of the adrenal medulla. In: Mohr U, Dungworth CC, Capen CC, eds. Pathobiology of the aging rat. vol 2. Washington, DC: ILSI, pp. 244–68, 1994. Tischler AS, Coupland RE. Changes in structure and function of the adrenal medulla. In: Mohr U, Dungworth CC, Capen CC, eds. Pathobiology of the aging rat. vol 2. Washington, DC: ILSI, pp. 244–68, 1994.
10.
go back to reference Tischler AS, DeLellis RA, Perlman RL, et al. Spontaneous proliferative lesions of the adrenal medulla in aging Long–Evans rats. Comparison to PC12 cells, small granule-containing cells, and human adrenal medullary hyperplasia. Lab Invest 53:486–98, 1985.PubMed Tischler AS, DeLellis RA, Perlman RL, et al. Spontaneous proliferative lesions of the adrenal medulla in aging Long–Evans rats. Comparison to PC12 cells, small granule-containing cells, and human adrenal medullary hyperplasia. Lab Invest 53:486–98, 1985.PubMed
11.
go back to reference Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73:2424–8, 1976.PubMedCrossRef Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73:2424–8, 1976.PubMedCrossRef
12.
go back to reference Powers JF, Schelling K, Brachold JM, et al. High-level expression of receptor tyrosine kinase ret and responsiveness to ret-activating ligands in pheochromocytoma cell lines from neurofibromatosis knockout mice. Mol Cell Neurosci 20:382–9, 2002.PubMedCrossRef Powers JF, Schelling K, Brachold JM, et al. High-level expression of receptor tyrosine kinase ret and responsiveness to ret-activating ligands in pheochromocytoma cell lines from neurofibromatosis knockout mice. Mol Cell Neurosci 20:382–9, 2002.PubMedCrossRef
13.
go back to reference Elkahloun AG, Powers JF, Nyska A, Eisenhofer G, Tischler AS. Gene expression profiling of rat pheochromocytoma. Ann NY Acad Sci 1073:290–9, 2006.PubMedCrossRef Elkahloun AG, Powers JF, Nyska A, Eisenhofer G, Tischler AS. Gene expression profiling of rat pheochromocytoma. Ann NY Acad Sci 1073:290–9, 2006.PubMedCrossRef
15.
go back to reference Pellegata NS, Quintanilla-Martinez L, Siggelkow H, et al. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci USA 103:15558–63, 2006.PubMedCrossRef Pellegata NS, Quintanilla-Martinez L, Siggelkow H, et al. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci USA 103:15558–63, 2006.PubMedCrossRef
16.
go back to reference Lee AK, DeLellis RA, Blount M, Nunnemacher G, Wolfe HJ. Pituitary proliferative lesions in aging male Long–Evans rats. A model of mixed multiple endocrine neoplasia syndrome. Lab Invest 47:595–602, 1982.PubMed Lee AK, DeLellis RA, Blount M, Nunnemacher G, Wolfe HJ. Pituitary proliferative lesions in aging male Long–Evans rats. A model of mixed multiple endocrine neoplasia syndrome. Lab Invest 47:595–602, 1982.PubMed
17.
go back to reference Powers JF, Brachold JM, Ehsani SA, Tischler AS. Up-regulation of ret by reserpine in the adult rat adrenal medulla. Neuroscience 132:605–12, 2005.PubMedCrossRef Powers JF, Brachold JM, Ehsani SA, Tischler AS. Up-regulation of ret by reserpine in the adult rat adrenal medulla. Neuroscience 132:605–12, 2005.PubMedCrossRef
18.
go back to reference Powers JF, Evinger MJ, Tsokas P, et al. Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice. Cell Tissue Res 302:309–20, 2000.PubMedCrossRef Powers JF, Evinger MJ, Tsokas P, et al. Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice. Cell Tissue Res 302:309–20, 2000.PubMedCrossRef
19.
go back to reference Le Hir H, Charlet-Berguerand N, Gimenez-Roqueplo A, et al. Relative expression of the RET9 and RET51 isoforms in human pheochromocytomas. Oncology 58:311–8, 2000.PubMedCrossRef Le Hir H, Charlet-Berguerand N, Gimenez-Roqueplo A, et al. Relative expression of the RET9 and RET51 isoforms in human pheochromocytomas. Oncology 58:311–8, 2000.PubMedCrossRef
20.
go back to reference Tsui-Pierchala BA, Ahrens RC, Crowder RJ, Milbrandt J, Johnson EM Jr. The long and short isoforms of Ret function as independent signaling complexes. J Biol Chem 277:34618–25, 2002.PubMedCrossRef Tsui-Pierchala BA, Ahrens RC, Crowder RJ, Milbrandt J, Johnson EM Jr. The long and short isoforms of Ret function as independent signaling complexes. J Biol Chem 277:34618–25, 2002.PubMedCrossRef
21.
go back to reference Reznik G, Germann P-G. Ganglioneuroma, adrenal, rat. In: Jones TC, Capen CC, Mohr U, eds. Endocrine system. 2nd ed. Berlin: Springer, pp. 427–32, 1996. Reznik G, Germann P-G. Ganglioneuroma, adrenal, rat. In: Jones TC, Capen CC, Mohr U, eds. Endocrine system. 2nd ed. Berlin: Springer, pp. 427–32, 1996.
22.
go back to reference Tischler AS, Powers JF, Pignatello M, Tsokas P, Downing JC, McClain RM. Vitamin D3-induced proliferative lesions in the rat adrenal medulla. Toxicol Sci 51:9–18, 1999.PubMedCrossRef Tischler AS, Powers JF, Pignatello M, Tsokas P, Downing JC, McClain RM. Vitamin D3-induced proliferative lesions in the rat adrenal medulla. Toxicol Sci 51:9–18, 1999.PubMedCrossRef
24.
go back to reference Pachnis V, Mankoo B, Costantini F. Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119:1005–17, 1993.PubMed Pachnis V, Mankoo B, Costantini F. Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119:1005–17, 1993.PubMed
25.
go back to reference Tischler AS, Greene LA. Phenotypic plasticity of pheochromocytoma and normal adrenal medullary cells. Adv Biochem Psychopharmacol 25:61–8, 1980.PubMed Tischler AS, Greene LA. Phenotypic plasticity of pheochromocytoma and normal adrenal medullary cells. Adv Biochem Psychopharmacol 25:61–8, 1980.PubMed
26.
go back to reference Olson L. Fluorescence histochemical evidence for axonal growth and secretion from transplanted adrenal medullary tissue. Histochemie 22:1–7, 1970.PubMedCrossRef Olson L. Fluorescence histochemical evidence for axonal growth and secretion from transplanted adrenal medullary tissue. Histochemie 22:1–7, 1970.PubMedCrossRef
27.
go back to reference Marek L, Levresse V, Amura C, et al. Multiple signaling conduits regulate global differentiation-specific gene expression in PC12 cells. J Cell Physiol 201:459–69, 2004.PubMedCrossRef Marek L, Levresse V, Amura C, et al. Multiple signaling conduits regulate global differentiation-specific gene expression in PC12 cells. J Cell Physiol 201:459–69, 2004.PubMedCrossRef
Metadata
Title
Adrenergic Differentiation and Ret Expression in Rat Pheochromocytomas
Authors
James F. Powers
Kristen L. Picard
Abraham Nyska
Arthur S. Tischler
Publication date
01-04-2008
Publisher
Humana Press Inc
Published in
Endocrine Pathology / Issue 1/2008
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-008-9019-1

Other articles of this Issue 1/2008

Endocrine Pathology 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.